Skip to search formSkip to main contentSkip to account menu

XT-611

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Effects of 1-benzylxanthines on cyclic AMP phosphodiesterase 4 isoenzyme.
Based on our results regarding the structure-activity relationships of alkylxanthines and imidazo[2,1-i]purines as… 
2004
2004
Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2
2003
2003
Prostaglandin E2‐Mediated Anabolic Effect of a Novel Inhibitor of Phosphodiesterase 4, XT‐611, in the In Vitro Bone Marrow Culture
The mechanism of osteoblast formation by a novel PDE4 inhibitor, XT‐611, was studied in the in vitro bone marrow culture system… 
2002
2002
Selective phosphodiesterase type 4 inhibitors reduce the prolonged survival of eosinophils stimulated by granulocyte-macrophage colony-stimulating factor.
It is well known that bronchial asthma is defined as chronic eosinophilic inflammation of the respiratory tract and that as one… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)